These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30471900)

  • 1. Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.
    Wagner BE; Langstraat CL; McGree ME; Weaver AL; Sarangi S; Mokri B; Dowdy SC; Cliby WA; Kumar A; Bakkum-Gamez JN
    Gynecol Oncol; 2019 Feb; 152(2):286-292. PubMed ID: 30471900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
    Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM
    Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.
    Shin W; Lee S; Lim MC; Jung J; Kim HJ; Cho H
    Cancer Med; 2021 Mar; 10(6):2045-2053. PubMed ID: 33638309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
    Manning-Geist BL; Alimena S; Del Carmen MG; Goodman A; Clark RM; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Gynecol Oncol; 2019 Apr; 153(1):63-67. PubMed ID: 30635213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer.
    Mokri B; Mariani A; Heit JA; Weaver AL; McGree ME; Martin JR; Lemens MA; Cliby WA; Bakkum-Gamez JN
    Int J Gynecol Cancer; 2013 Nov; 23(9):1684-91. PubMed ID: 24172104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
    Zhou Q; Zhu C; Shen Z; Zhang T; Li M; Zhu J; Qin J; Xie Y; Zhang W; Chen R; Wang G; Qian L; Wu D; Nashan B; Zhou Y
    Eur J Surg Oncol; 2020 May; 46(5):855-861. PubMed ID: 32001042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.
    Abu-Rustum NR; Richard S; Wilton A; Lev G; Sonoda Y; Hensley ML; Gemignani M; Barakat RR; Chi DS
    Gynecol Oncol; 2005 Nov; 99(2):320-6. PubMed ID: 16061278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.
    Greco PS; Bazzi AA; McLean K; Reynolds RK; Spencer RJ; Johnston CM; Liu JR; Uppal S
    Obstet Gynecol; 2017 Jun; 129(6):979-985. PubMed ID: 28486358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer.
    Timmermans M; van der Aa MA; Lalisang RI; Witteveen PO; Van de Vijver KK; Kruitwagen RF; Sonke GS
    Gynecol Oncol; 2018 Sep; 150(3):446-450. PubMed ID: 30001834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and pharmacologic prophylaxis for venous thromboembolism in elective spine surgery.
    McLynn RP; Diaz-Collado PJ; Ottesen TD; Ondeck NT; Cui JJ; Bovonratwet P; Shultz BN; Grauer JN
    Spine J; 2018 Jun; 18(6):970-978. PubMed ID: 29056565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
    Salinaro JR; McQuillen K; Stemple M; Boccaccio R; Ehrisman J; Lorenzo AM; Havrilesky L; Secord AA; Galvan Turner V; Moore KN; Davidson B
    Int J Gynecol Cancer; 2020 Apr; 30(4):491-497. PubMed ID: 32054646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk of venous thromboembolism according to primary treatment type in women with endometrial cancer: a population-based study.
    Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Cho YK; Kim YB
    BMC Cancer; 2021 Oct; 21(1):1166. PubMed ID: 34717579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Using Four Different Data Collection Methods: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study.
    Smith S; Lambert P; Nachtigal MW; Altman AD
    J Obstet Gynaecol Can; 2022 May; 44(5):475-481. PubMed ID: 34718149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
    Black D; Iasonos A; Ahmed H; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer.
    Kim JS; Mills KA; Fehniger J; Liao C; Hurteau JA; Kirschner CV; Lee NK; Rodriguez GC; Yamada SD; Diaz Moore ES; Tenney ME
    Int J Gynecol Cancer; 2017 Oct; 27(8):1774-1782. PubMed ID: 28708786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgery.
    Kukreja JE; Levey HR; Scosyrev E; Kiernan M; Berrondo C; McNamee C; Wu G; Joseph JV; Ghazi A; Rashid H; Dozier A; Messing EM
    Urol Oncol; 2015 Sep; 33(9):387.e7-16. PubMed ID: 25637953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in epithelial ovarian cancer. A prospective cohort study.
    Kahr HS; Christiansen OB; Grove A; Iyer V; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
    Thromb Res; 2019 Sep; 181():112-119. PubMed ID: 31400621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous Thromboembolic Events Following Major Pelvic and Abdominal Surgeries for Cancer: A Prospective Cohort Study.
    Serrano PE; Parpia S; Linkins LA; Elit L; Simunovic M; Ruo L; Bhandari M; Levine M
    Ann Surg Oncol; 2018 Oct; 25(11):3214-3221. PubMed ID: 30051364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
    Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
    PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.